Pathology would be of interest in bvFTD to differentiate those with tau versus TDP43 pathology, although consensus clinical diagnostic criteria are reliable in separating bvFTD from Alzheimer’s disease. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.